Genstar in $790m research lab deal
San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.
San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.
Copyright PEI Media
Not for publication, email or dissemination